Synthesis and In Vivo Antiarrhythmic Activity Evaluation of Novel Scutellarein Analogues as Voltage-Gated Nav1.5 and Cav1.2 Channels Blockers

Wei Yang,Wenping Wang,Song Cai,Peng Li,Die Zhang,Jinhua Ning,Jin Ke,Anguo Hou,Linyun Chen,Yunshu Ma,Wenbin Jin

DOI: https://doi.org/10.3390/molecules28217417

IF: 4.6

2023-11-03

Molecules

Abstract:Malignant cardiac arrhythmias with high morbidity and mortality have posed a significant threat to our human health. Scutellarein, a metabolite of Scutellarin which is isolated from Scutellaria altissima L., presents excellent therapeutic effects on cardiovascular diseases and could further be metabolized into methylated forms. A series of 22 new scutellarein derivatives with hydroxyl-substitution based on the scutellarin metabolite in vivo was designed, synthesized via the conjugation of the scutellarein scaffold with pharmacophores of FDA-approved antiarrhythmic medications and evaluated for their antiarrhythmic activity through the analyzation of the rat number of arrhythmia recovery, corresponding to the recovery time and maintenance time in the rat model of barium chloride-induced arrhythmia, as well as the cumulative dosage of aconitine required to induce VP, VT, VF and CA in the rat model of aconitine-induced arrhythmia. All designed compounds could shorten the time of the arrhythmia continuum induced by barium chloride, indicating that 4′-hydroxy substituents of scutellarein had rapid-onset antiarrhythmic effects. In addition, nearly all of the compounds could normalize the HR, RR, QRS, QT and QTc interval, as well as the P/T waves’ amplitude. The most promising compound 10e showed the best antiarrhythmic activity with long-term efficacy and extremely low cytotoxicity, better than the positive control scutellarein. This result was also approved by the computational docking simulation. Most importantly, patch clamp measurements on Nav1.5 and Cav1.2 channels indicated that compound 10e was able to reduce the INa and ICa in a concentration-dependent manner and left-shifted the inactivation curve of Nav1.5. Taken together, all compounds were considered to be antiarrhythmic. Compound 10e even showed no proarrhythmic effect and could be classified as Ib Vaughan Williams antiarrhythmic agents. What is more, compound 10e did not block the hERG potassium channel which highly associated with cardiotoxicity.

chemistry, multidisciplinary,biochemistry & molecular biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the threat to human health posed by the high incidence and mortality of malignant arrhythmias (such as ventricular tachycardia, ventricular fibrillation and cardiac arrest). Specifically, the research aims to design and synthesize a series of new flavonoid compounds - isoorientin derivatives, and evaluate the in - vivo anti - arrhythmic activities of these compounds as voltage - gated NaV1.5 and CaV1.2 channel blockers. In this way, researchers hope to discover new anti - arrhythmic drugs that are more effective and have fewer side effects.

The research background indicates that although most of the anti - arrhythmic drugs currently used in clinical practice are effective, they all have different degrees of pro - arrhythmic effects to some extent. Therefore, screening natural products acting on multiple ion channels from traditional Chinese medicine as anti - arrhythmic drugs is an important research direction. In particular, the researchers focused on starting from the flavonoid compound isoorientin, designed and synthesized 22 new derivatives. These derivatives structurally combine the isoorientin skeleton with the pharmacophores of anti - arrhythmic drugs approved by the FDA, in order to improve the drug efficacy by changing their metabolic stability and bioavailability.

To evaluate the anti - arrhythmic effects of these new compounds, the research used a rat model of arrhythmia induced by barium chloride, and detected the number of arrhythmia recoveries, the recovery time and the maintenance time, as well as electrocardiogram parameters such as heart rate (HR), QT interval (QT), QRS interval, corrected QT interval (QTc) and the amplitudes of P - wave/T - wave. In addition, the cumulative doses of aconitine required to cause premature ventricular contractions (VP), ventricular tachycardia (VT), ventricular fibrillation (VF) and cardiac arrest (CA) were also determined.

Furthermore, in order to reveal the anti - arrhythmic mechanisms of these compounds, the research also investigated their effects on voltage - gated NaV1.5 and CaV1.2 channels. The results showed that the most promising compound 10e not only exhibited the best anti - arrhythmic activity, but also had a significant long - term efficacy and extremely low cytotoxicity, which was superior to the positive control isoorientin. Moreover, 10e did not block the hERG potassium channel highly related to cardiotoxicity, indicating that it may be classified as the Ib subclass in Vaughan Williams class I anti - arrhythmic drugs.